Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-12-28

Clinical Trial Update: A Multi-national Study to Identify Treatment Discontinuation Rate in de Novo Alzheimer's Disease Patients Who Have Been Newly Prescribed With Donepezil (Aricept) in Asia (ADOS)

View source ↗

Summary

A multinational observational study completed in Asia examining how often patients with de novo Alzheimer's disease discontinue donepezil (Aricept) after initia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aricept (Donepezil)

Snippet

Sponsor: Eisai Korea Inc. | Conditions: Alzheimer's Disease | Status: COMPLETED